A Trial Investigating the Pharmacokinetic Properties of Biphasic Insulin Aspart 50 (BIAsp 50) in Healthy Chinese Subjects.
Phase of Trial: Phase I
Latest Information Update: 05 Jun 2015
At a glance
- Drugs Insulin aspart/insulin protamine aspart (Primary)
- Indications Diabetes mellitus
- Focus Pharmacokinetics
- Sponsors Novo Nordisk
- 23 Dec 2011 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 02 Mar 2011 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov.
- 03 Jan 2011 Planned initiation date changed from 1 Nov 2010 to 1 Feb 2011 as reported by ClinicalTrials.gov.